MSLN overexpression + PD-L1 overexpression
|
Solid Tumor
|
MSLN overexpression + PD-L1 overexpression
|
Solid Tumor
|
ATA3271 Sensitive: D – Preclinical
|
ATA3271 Sensitive: D – Preclinical
|
MSLN overexpression + PD-L1 overexpression
|
Mesothelioma
|
MSLN overexpression + PD-L1 overexpression
|
Mesothelioma
|
ATA3271 Sensitive: D – Preclinical
|
ATA3271 Sensitive: D – Preclinical
|